OmniGuide's flexible laser tech:
This article was originally published in Clinica
OmniGuide has CE-marked for sale in Europe its flexible CO2 laser fibres for use in minimally-invasive surgery. Its OtoBeam and BeamPath systems, which are already approved in the US, can now be sold in all countries that accept the CE-mark, said the Cambridge, Massachusetts firm. Most CO2 lasers have a rigid articulating arm that limits the surgeon to procedures where a "line-of-sight" from outside the patient's body is possible, the firm claimed. The OmniGuide fibre, which is fitted to this existing base of CO2 laser systems, allows physicians to place the fibre into the patient's body under endoscopic guidance to treat lesions within the skull base, airway and larynx.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.